Skip to content

Revvity RVTY Other Financing

Other Financing at other companies

Danaher logo
DanaherDHR
-$28M-233%
IQVIA logo
IQVIAIQV
$4M-33.3%
Labcorp Holdings logo
Labcorp HoldingsLH
-$3.4M-3.0%
Quest Diagnostics logo
Quest DiagnosticsDGX
-$84M-37.7%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
-$2M+66.7%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's other financing?
Revvity (RVTY) reported other financing of $0 in Q1 2026.
How has Revvity's other financing changed year-over-year?
Revvity's other financing decreased by 100.0% year-over-year, from $1.82M to $0.